EVOFEM BIOSCIENCES
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products. The company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
EVOFEM BIOSCIENCES
Industry:
Biopharma Health Care Medical Women's
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.evofem.com
Total Employee:
101+
Status:
Active
Contact:
+858.550.1900
Total Funding:
470.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
2014-08-01
Board_member
Board_member
2007-03-01
Board_member
2011-04-01
Board_member
2011-03-01
Board_member
2014-07-01
Current Employees Featured
Saundra Pelletier CEO @ Evofem Biosciences
CEO
2013-02-01
Jay File Chief Financial Officer @ Evofem Biosciences
Chief Financial Officer
2015-03-01
David R. Friend CSO @ Evofem Biosciences
CSO
2015-01-01
Kelly Culwell Chief Medical Officer @ Evofem Biosciences
Chief Medical Officer
Russell Barrans Chief Commercial Officer @ Evofem Biosciences
Chief Commercial Officer
2015-01-01
Chris Kemmerer VP - Pharmaceutical Development & Manufacturing @ Evofem Biosciences
VP - Pharmaceutical Development & Manufacturing
Stewart M. Brown Vice President & Deputy General Counsel @ Evofem Biosciences
Vice President & Deputy General Counsel
2019-08-01
Katherine Atkinson EVP, Commercial Operations @ Evofem Biosciences
EVP, Commercial Operations
2021-11-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-01-17 | Neothetics | Neothetics acquired by Evofem Biosciences | N/A |
Investors List
Keystone Capital
Keystone Capital investment in Post-IPO Equity - Evofem Biosciences
Adjuvant Capital
Adjuvant Capital investment in Post-IPO Debt - Evofem Biosciences
PDL Biopharma
PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences
PDL Biopharma
PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences
Woodford Investment Management
Woodford Investment Management investment in Post-IPO Equity - Evofem Biosciences
Domain Associates
Domain Associates investment in Series C - Evofem Biosciences
AKS Capital
AKS Capital investment in Series C - Evofem Biosciences
Alta Partners
Alta Partners investment in Series C - Evofem Biosciences
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series C - Evofem Biosciences
RUSNANO
RUSNANO investment in Series C - Evofem Biosciences
Official Site Inspections
http://www.evofem.com Semrush global rank: 1.24 M Semrush visits lastest month: 24.44 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Evofem Biosciences"
About Us - Evofem Biosciences, Inc.
Mailing Address: 7770 Regents Road Suite 113-618 San Diego, California 92122 1.858.550.1900. Headquarters: 12636 High Bluff Drive, Suite 400 San Diego, CA 92130See details»
Evofem Biosciences Management Team - Saundra Pelletier, CEO
She joined Evofem as Chief Financial Officer and Secretary in April 2023 and leads the Company’s finance organization and financial activities including financial planning and …See details»
Evofem Biosciences - Crunchbase Company Profile
Organization. Evofem Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Evofem Biosciences - Funding, Financials, Valuation & Investors
Jan 17, 2018 Evofem Biosciences is registered under the ticker OTCQB:EVFM . Evofem Biosciences is funded by 16 investors. Aditxt Therapeutics and Keystone Capital are the most …See details»
Evofem Biosciences, Inc. - AnnualReports.com
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and …See details»
Evofem Biosciences Company Description - Stock Analysis
Jan 24, 2025 Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive …See details»
Evofem Reports Fourth Consecutive Year of Net Sales Growth
19 hours ago Evofem relaunched SOLOSEC in November 2024 through its dedicated U.S. women's health commercial team. Sales and marketing expense was 47% of net sales for …See details»
Revolutionizing Women’s Sexual and Reproductive Health
Feb 15, 2022 •Evofem’sability to obtain the necessary regulatory approvals for its product candidates and the timing of such approvals, and, •Any other risk factors detailed in Evofem’s …See details»
Evofem - Overview, News & Similar companies | ZoomInfo.com
Apr 18, 2024 Evofem Biosciences Announces Financial Results for the First Quarter of 2024 SAN DIEGO, May 15, 2024 /PRNewswire/ -- The company behind the hormone-free …See details»
Evofem Biosciences - Contacts, Employees, Board Members
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products. New. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
EVFM Board of Directors - Evofem Biosciences, Inc.
Tony O’Brien. Mr. O’Brien has served as a member of the Evofem Biosciences board of directors since January 2018. He served as the Director General of Ireland’s Health Service Executive, …See details»
EVFM Investor Presentation 24 MAR 2025 FINAL
• Evofem’sability to retain members of its management and other key personnel and to expand its organization to accommodate potential growth • Evofem’sability to maintain and protect its …See details»
Evofem Biosciences Company Profile - Office Locations ... - Craft
Oct 29, 2024 Evofem Biosciences has 3 employees at their 1 location and $18.22 m in annual revenue in FY 2023. See insights on Evofem Biosciences including office locations, …See details»
Evofem Biosciences Reports Fourth Year of Continuous Revenue …
1 day ago Evofem Biosciences is committed to addressing unmet needs in women's sexual and reproductive health through its products PHEXXI and SOLOSEC, which highlight the …See details»
Saundra Pelletier - Evofem Biosciences, Inc.
Saundra Pelletier has served as Chief Executive Officer, President and Executive Director of Evofem Biosciences since February 2015, and as interim Chair of the Board since November …See details»
Evofem Biosciences Inc. (EVFM) reports earnings - Quartz
1 day ago Evofem Biosciences Inc. (EVFM +7.76%) has submitted its 10-K filing for the fiscal year ended December 31, 2024. Suggested Reading The 5 best places in America to buy a …See details»
Revolutionizing Women’s Sexual and Reproductive Health
Oct 6, 2021 Revolutionizing Women’s Sexual and Reproductive Health October 2021 NASDAQ: EVFM evofem.com © 2021 Evofem Biosciences, Inc. | For investor discussions only.See details»
Evofem Reports Fourth Consecutive Year of Net Sales Growth - PR …
19 hours ago -- 2024 Net Sales Increased 6% to $19.4 Million ---- Total Operating Expense Reduced 27% from 2023 Levels, Excluding Non-cash Amortization Expense ---- Sales and …See details»
Evofem Reports Fourth Consecutive Year of Net Sales Growth
19 hours ago Women's health innovator Evofem Biosciences, Inc. , today announced financial results for the fourth quarter and year ended December 31, 2024. Highlights include:...See details»
Corporate Mission - Evofem Biosciences, Inc.
Evofem’s sole purpose is to improve the quality of lives of women worldwide by. providing them with more control over their sexual and reproductive health. We are passionately committed to …See details»